Companhia Brasileira de Distribuicao (NYSE:CBD)’s share price dropped 2.1% during mid-day trading on Wednesday . The stock traded as low as $13.72 and last traded at $13.84, with a volume of 301,408 shares changing hands. The stock had previously closed at $14.14.

A number of brokerages have weighed in on CBD. Deutsche Bank AG raised Companhia Brasileira de Distribuicao from a “hold” rating to a “buy” rating in a report on Tuesday, June 7th. Zacks Investment Research raised Companhia Brasileira de Distribuicao from a “sell” rating to a “hold” rating in a report on Tuesday, June 14th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. Companhia Brasileira de Distribuicao presently has a consensus rating of “Hold” and an average price target of $10.17.

The firm’s 50 day moving average price is $12.59 and its 200 day moving average price is $12.02. The firm has a market cap of $3.71 billion and a P/E ratio of 47.71.

A hedge fund recently raised its stake in Companhia Brasileira de Distribuicao stock. Brandes Investment Partners LP boosted its stake in shares of Companhia Brasileira de Distribuicao (NYSE:CBD) by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,095,051 shares of the company’s stock after buying an additional 110,038 shares during the period. Brandes Investment Partners LP owned 0.79% of Companhia Brasileira de Distribuicao worth $22,040,000 as of its most recent SEC filing.

Companhia Brasileira de Distribuicao, directly or through its subsidiaries, is engaged in the retail of food, clothing, home appliances, electronics and other items through its chain of hypermarkets, supermarkets, specialized stores and department stores. The Company’s operating segments include Retail segment, Cash and carry segment, Home appliances segment and E-commerce segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.